Key Points
- CEO Robert Jr. Spignesi sold 38,327 shares on Feb. 19 at an average price of $3.89 for about $149,092, trimming his stake by 3.13% to 1,187,770 shares.
- Shares trade around $3.89 with a market cap of ~$172.4M, a negative P/E, and a 52‑week range of $1.86–$4.94, with 50‑ and 200‑day moving averages near $3.67 and $3.41 respectively.
- The stock has a consensus rating of "Hold" (average target $8.00), with one Buy and one Sell from analysts, and roughly 52.6% of shares owned by institutions.
Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) COO John Addington Wilson sold 5,403 shares of the firm's stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $3.92, for a total value of $21,179.76. Following the sale, the chief operating officer directly owned 326,365 shares in the company, valued at approximately $1,279,350.80. This represents a 1.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Rapid Micro Biosystems Stock Down 2.0%
Shares of NASDAQ:RPID traded down $0.08 during mid-day trading on Friday, reaching $3.89. 131,328 shares of the stock were exchanged, compared to its average volume of 231,064. The stock's 50 day simple moving average is $3.67 and its 200-day simple moving average is $3.41. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The company has a market cap of $172.40 million, a P/E ratio of -3.85 and a beta of 1.38. Rapid Micro Biosystems, Inc. has a one year low of $1.86 and a one year high of $4.94.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the company. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Rapid Micro Biosystems in a report on Thursday, January 22nd. Wall Street Zen raised shares of Rapid Micro Biosystems from a "sell" rating to a "hold" rating in a report on Saturday, February 14th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $8.00.
Check Out Our Latest Stock Analysis on Rapid Micro Biosystems
Institutional Investors Weigh In On Rapid Micro Biosystems
Several institutional investors and hedge funds have recently made changes to their positions in the business. Hudson Bay Capital Management LP bought a new stake in shares of Rapid Micro Biosystems in the 3rd quarter valued at $38,000. American Century Companies Inc. raised its stake in shares of Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company's stock worth $58,000 after purchasing an additional 5,341 shares during the last quarter. Fifth Lane Capital LP bought a new position in Rapid Micro Biosystems during the 4th quarter valued at $51,000. OMERS ADMINISTRATION Corp purchased a new position in Rapid Micro Biosystems during the fourth quarter worth about $71,000. Finally, Barclays PLC purchased a new stake in shares of Rapid Micro Biosystems during the fourth quarter valued at approximately $72,000. Institutional investors own 52.60% of the company's stock.
About Rapid Micro Biosystems
(
Get Free Report)
Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company's technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.
In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
